Advertisement

Index by Author

January 1979; 28 (1)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abreu, J F

    • Detection of early retinal changes in diabetes by vitreous fluorophotometry. Diabetes January 1979 28:16-19; doi:10.2337/diabetes.28.1.16

  2. Atkinson, R L

    • Effects of fasting on gluconeogenesis from alanine in nondiabetic man. Diabetes January 1979 28:56-60

B

  1. Bégin-Heick, N

    • Regranulation of islets of Langerhans and normalization of in vivo insulin secretion in ob/ob mice treated with oxytetracycline. Diabetes January 1979 28:65-70; doi:10.2337/diabetes.28.1.65

  2. Bernstein, R

    • Defect in glucose removal in nonketotic diabetic patients with fasting hyperglycemia. Diabetes January 1979 28:32-34

  3. Burr, I M

    • Effects of calcium, lanthanum, and bicarbonate ion on epinephrine modification of insulin release in vitro. Diabetes January 1979 28:52-55; doi:10.2337/diabetes.28.1.52

C

  1. Cherrington, A D

    • Effects of fasting on gluconeogenesis from alanine in nondiabetic man. Diabetes January 1979 28:56-60

  2. Chiasson, J L

    • Effects of fasting on gluconeogenesis from alanine in nondiabetic man. Diabetes January 1979 28:56-60

  3. Clarke, W L

    • Closed-loop and open-loop devices for blood glucose control in normal and diabetic subjects. Diabetes January 1979 28:71-84

  4. Clemens, A H

    • Closed-loop and open-loop devices for blood glucose control in normal and diabetic subjects. Diabetes January 1979 28:71-84

  5. Cunha-Vaz, J G

    • Detection of early retinal changes in diabetes by vitreous fluorophotometry. Diabetes January 1979 28:16-19; doi:10.2337/diabetes.28.1.16

D

  1. Davis, B M

    • Defect in glucose removal in nonketotic diabetic patients with fasting hyperglycemia. Diabetes January 1979 28:32-34

E

  1. Eaton, R P

    • The regulation of plasma ketone body concentration by counter-regulatory hormones in man. III. Effects of norepinephrine in normal man. Diabetes January 1979 28:5-10

F

  1. Fonseca, J R

    • Detection of early retinal changes in diabetes by vitreous fluorophotometry. Diabetes January 1979 28:16-19; doi:10.2337/diabetes.28.1.16

G

  1. Gabbay, K H

    • Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine. Diabetes January 1979 28:35-40; doi:10.2337/diabetes.28.1.35

  2. Gersell, D J

    • Regional distribution and concentration of pancreatic polypeptide in the human and canine pancreas. Diabetes January 1979 28:11-15; doi:10.2337/diabetes.28.1.11

  3. Gingerich, R L

    • Regional distribution and concentration of pancreatic polypeptide in the human and canine pancreas. Diabetes January 1979 28:11-15; doi:10.2337/diabetes.28.1.11

  4. Greider, M H

    • Regional distribution and concentration of pancreatic polypeptide in the human and canine pancreas. Diabetes January 1979 28:11-15; doi:10.2337/diabetes.28.1.11

H

  1. Heick, H M

    • Regranulation of islets of Langerhans and normalization of in vivo insulin secretion in ob/ob mice treated with oxytetracycline. Diabetes January 1979 28:65-70; doi:10.2337/diabetes.28.1.65

  2. Hidalgo, R

    • Juvenile-onset diabetes HLA-A, -B, -C, and -DR alloantigens. Diabetes January 1979 28:1-4; doi:10.2337/diabetes.28.1.1

K

  1. Keller, U

    • Effects of fasting on gluconeogenesis from alanine in nondiabetic man. Diabetes January 1979 28:56-60

  2. Kipnis, D M

    • Closed-loop and open-loop devices for blood glucose control in normal and diabetic subjects. Diabetes January 1979 28:71-84

  3. Kleinman, H K

    • Studies of cultured human fibroblasts in diabetes mellitus: changes in heparan sulfate. Diabetes January 1979 28:61-64; doi:10.2337/diabetes.28.1.61

  4. Kolterman, O

    • Defect in glucose removal in nonketotic diabetic patients with fasting hyperglycemia. Diabetes January 1979 28:32-34

L

  1. Lacy, W W

    • Effects of fasting on gluconeogenesis from alanine in nondiabetic man. Diabetes January 1979 28:56-60

  2. Liljenquist, J E

    • Effects of fasting on gluconeogenesis from alanine in nondiabetic man. Diabetes January 1979 28:56-60

  3. Loo, S

    • Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine. Diabetes January 1979 28:35-40; doi:10.2337/diabetes.28.1.35

  4. Lorenz, R

    • Effects of calcium, lanthanum, and bicarbonate ion on epinephrine modification of insulin release in vitro. Diabetes January 1979 28:52-55; doi:10.2337/diabetes.28.1.52

N

  1. Norman, M G

    • Regranulation of islets of Langerhans and normalization of in vivo insulin secretion in ob/ob mice treated with oxytetracycline. Diabetes January 1979 28:65-70; doi:10.2337/diabetes.28.1.65

O

  1. Olefsky, J M

    • Defect in glucose removal in nonketotic diabetic patients with fasting hyperglycemia. Diabetes January 1979 28:32-34

P

  1. Patel, Y C

    • Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine. Diabetes January 1979 28:35-40; doi:10.2337/diabetes.28.1.35

  2. Pek, S

    • Inhibition of glucagon secretion by diazoxide in vitro. Diabetes January 1979 28:26-31; doi:10.2337/diabetes.28.1.26

  3. Poffenbarger, P L

    • Pharmacogenetics of tolbutamide metabolism in humans. Diabetes January 1979 28:41-51; doi:10.2337/diabetes.28.1.41

R

  1. Reaven, G M

    • Defect in glucose removal in nonketotic diabetic patients with fasting hyperglycemia. Diabetes January 1979 28:32-34

  2. Röjdmark, S

    • Effect of verapamil on insulin response to alcohol hypoglycemia in patients with primary hyperparathyroidism. Diabetes January 1979 28:21-25; doi:10.2337/diabetes.28.1.21

  3. Ruas, M A

    • Detection of early retinal changes in diabetes by vitreous fluorophotometry. Diabetes January 1979 28:16-19; doi:10.2337/diabetes.28.1.16

S

  1. Samols, E

    • Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine. Diabetes January 1979 28:35-40; doi:10.2337/diabetes.28.1.35

  2. Santiago, J C

    • Inhibition of glucagon secretion by diazoxide in vitro. Diabetes January 1979 28:26-31; doi:10.2337/diabetes.28.1.26

  3. Santiago, J V

    • Closed-loop and open-loop devices for blood glucose control in normal and diabetic subjects. Diabetes January 1979 28:71-84

  4. Schade, D S

    • The regulation of plasma ketone body concentration by counter-regulatory hormones in man. III. Effects of norepinephrine in normal man. Diabetes January 1979 28:5-10

  5. Scott, J

    • Pharmacogenetics of tolbutamide metabolism in humans. Diabetes January 1979 28:41-51; doi:10.2337/diabetes.28.1.41

  6. Sharp, R

    • Effects of calcium, lanthanum, and bicarbonate ion on epinephrine modification of insulin release in vitro. Diabetes January 1979 28:52-55; doi:10.2337/diabetes.28.1.52

  7. Silbert, C K

    • Studies of cultured human fibroblasts in diabetes mellitus: changes in heparan sulfate. Diabetes January 1979 28:61-64; doi:10.2337/diabetes.28.1.61

  8. Sinclair-Smith, B C

    • Effects of fasting on gluconeogenesis from alanine in nondiabetic man. Diabetes January 1979 28:56-60

  9. Singal, D P

    • Juvenile-onset diabetes HLA-A, -B, -C, and -DR alloantigens. Diabetes January 1979 28:1-4; doi:10.2337/diabetes.28.1.1

  10. Solow, H

    • Juvenile-onset diabetes HLA-A, -B, -C, and -DR alloantigens. Diabetes January 1979 28:1-4; doi:10.2337/diabetes.28.1.1

U

  1. Urdanivia, E

    • Inhibition of glucagon secretion by diazoxide in vitro. Diabetes January 1979 28:26-31; doi:10.2337/diabetes.28.1.26

W

  1. Weir, G C

    • Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine. Diabetes January 1979 28:35-40; doi:10.2337/diabetes.28.1.35

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement